Home > Publications database > The SCF-FBXW7 E3 ubiquitin ligase triggers degradation of Histone 3 Lysine 4 methyltransferase complex component WDR5 to prevent mitotic slippage. > print |
001 | 182682 | ||
005 | 20240229145727.0 | ||
024 | 7 | _ | |a 10.1016/j.jbc.2022.102703 |2 doi |
024 | 7 | _ | |a pmid:36395886 |2 pmid |
024 | 7 | _ | |a 0021-9258 |2 ISSN |
024 | 7 | _ | |a 1067-8816 |2 ISSN |
024 | 7 | _ | |a 1083-351X |2 ISSN |
024 | 7 | _ | |a altmetric:138602178 |2 altmetric |
037 | _ | _ | |a DKFZ-2022-02850 |
041 | _ | _ | |a English |
082 | _ | _ | |a 540 |
100 | 1 | _ | |a Hänle-Kreidler, Simon |0 P:(DE-He78)d4c68225ca6cd393718be733a8e4097d |b 0 |e First author |u dkfz |
245 | _ | _ | |a The SCF-FBXW7 E3 ubiquitin ligase triggers degradation of Histone 3 Lysine 4 methyltransferase complex component WDR5 to prevent mitotic slippage. |
260 | _ | _ | |a Bethesda, Md. |c 2022 |b Soc. |
336 | 7 | _ | |a article |2 DRIVER |
336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1671705943_12658 |2 PUB:(DE-HGF) |
336 | 7 | _ | |a ARTICLE |2 BibTeX |
336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
500 | _ | _ | |a ISSN 0021-9258 / #EA:F045#LA:F045# |
520 | _ | _ | |a During prolonged mitotic arrest induced by anti-microtubule drugs, cell fate decision is determined by two alternative pathways, one leading to cell death, the other inducing premature escape from mitosis by mitotic slippage. FBWX7, a member of the F-box family of proteins and substrate-targeting subunit of the SCF (SKP1-CUL1-F-Box) E3 ubiquitin ligase complex promotes mitotic cell death and prevents mitotic slippage, but molecular details underlying these roles for FBWX7 are unclear. In this study, we report that WDR5, a component of the mixed lineage leukemia (MLL) complex of Histone 3 Lysine 4 (H3K4) methyltransferases, is a substrate of FBXW7. We determined by co-immunoprecipitation experiments and in vitro binding assays that WDR5 interacts with FBXW7 in vivo and in vitro. SCF-FBXW7 mediates ubiquitination of WDR5 and targets it for proteasomal degradation. Furthermore, we find that WDR5 depletion counteracts FBXW7 loss-of-function by reducing mitotic slippage and polyploidization. In conclusion, our data elucidate a new mechanism in mitotic cell fate regulation which might contribute to prevent chemotherapy resistance in patients after anti-microtubule drug treatment. |
536 | _ | _ | |a 316 - Infektionen, Entzündung und Krebs (POF4-316) |0 G:(DE-HGF)POF4-316 |c POF4-316 |f POF IV |x 0 |
588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de |
650 | _ | 7 | |a FBXW7 |2 Other |
650 | _ | 7 | |a WDR5 |2 Other |
650 | _ | 7 | |a chemoresistance |2 Other |
650 | _ | 7 | |a mitotic slippage |2 Other |
650 | _ | 7 | |a ubiquitylation (ubiquitination) |2 Other |
700 | 1 | _ | |a Richter, Kai |0 P:(DE-He78)f08cb94a1ca44e0f65e828ea1c2edca4 |b 1 |
700 | 1 | _ | |a Hoffmann, Ingrid |0 P:(DE-He78)b97fa0c782a162d952b6197f3b916379 |b 2 |e Last author |u dkfz |
773 | _ | _ | |a 10.1016/j.jbc.2022.102703 |g p. 102703 - |0 PERI:(DE-600)1474604-9 |n 12 |p 102703 |t The journal of biological chemistry |v 298 |y 2022 |x 0021-9258 |
909 | C | O | |p VDB |o oai:inrepo02.dkfz.de:182682 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 0 |6 P:(DE-He78)d4c68225ca6cd393718be733a8e4097d |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 1 |6 P:(DE-He78)f08cb94a1ca44e0f65e828ea1c2edca4 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 2 |6 P:(DE-He78)b97fa0c782a162d952b6197f3b916379 |
913 | 1 | _ | |a DE-HGF |b Gesundheit |l Krebsforschung |1 G:(DE-HGF)POF4-310 |0 G:(DE-HGF)POF4-316 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Infektionen, Entzündung und Krebs |x 0 |
914 | 1 | _ | |y 2022 |
915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b J BIOL CHEM : 2019 |d 2021-05-04 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2021-05-04 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2021-05-04 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0320 |2 StatID |b PubMed Central |d 2021-05-04 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |d 2021-05-04 |
915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |d 2021-05-04 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2021-05-04 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |d 2021-05-04 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2021-05-04 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2021-05-04 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1190 |2 StatID |b Biological Abstracts |d 2021-05-04 |
915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2021-05-04 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2021-05-04 |
915 | _ | _ | |a IF < 5 |0 StatID:(DE-HGF)9900 |2 StatID |d 2021-05-04 |
920 | 2 | _ | |0 I:(DE-He78)F045-20160331 |k F045 |l F045 Zellzykluskontrolle und Karzinogenese |x 0 |
920 | 1 | _ | |0 I:(DE-He78)F045-20160331 |k F045 |l F045 Zellzykluskontrolle und Karzinogenese |x 0 |
920 | 0 | _ | |0 I:(DE-He78)F045-20160331 |k F045 |l F045 Zellzykluskontrolle und Karzinogenese |x 0 |
980 | _ | _ | |a journal |
980 | _ | _ | |a VDB |
980 | _ | _ | |a I:(DE-He78)F045-20160331 |
980 | _ | _ | |a UNRESTRICTED |
Library | Collection | CLSMajor | CLSMinor | Language | Author |
---|